Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
(ABT - Get Report) rated new Hold at Deutsche. $53 price target. Sales of the company's lead drug, Humira, could be slowing.
(CNL - Get Report) downgraded at Wells Fargo from Outperform to Market Perform, Wells Fargo said. Valuation call.
(CRM - Get Report)
upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $170 price target. Diversification efforts are gaining traction.
(ICE - Get Report)
upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $147 price target.
(TZOO - Get Report)
downgraded at Benchmark Company from Buy to Hold. Valuation call, based on a $66 price target.
End of report.